Sponsored by:

Molecular Imaging: Page 439

Draxis confirms sell-off rumors
By AuntMinnie.com staff writers
Canadian radiopharmaceutical developer Draxis Health of Montreal confirmed that it is in discussions that could lead to a sale of the company to another firm.
March 16, 2008
MagnaWand releases MRSA cleaning tool
By AuntMinnie.com staff writers
MagnaWand of Newtown, PA, is introducing a nonmagnetic tool designed to clean and disinfect MRI, PET, and CT scanners.
March 13, 2008
Cytogen's revenues, net loss up in 2007
By AuntMinnie.com staff writers
Increased product sales boosted revenues at biopharmaceutical firm Cytogen's financial results in the fourth quarter (end-December 31) and for 2007, although the company's full-year net loss jumped.
March 13, 2008
IBA opens U.K. production center
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has received the go-ahead from U.K. authorities to begin operations at its new PET radiopharmaceuticals production site in Guildford, U.K., according to the company.
March 13, 2008
Neoprobe announces phase II Lymphoseek results
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe of Dublin, OH, has unveiled results from a multicenter phase II clinical study for its radiopharmaceutical agent, Lymphoseek, the company reported.
March 12, 2008
European molecular imaging market grows
By AuntMinnie.com staff writers
The European molecular imaging market continues to expand, despite low reimbursement rates, pricing pressures, and high competition levels, according to market research firm Frost & Sullivan.
March 11, 2008
FDA clears software for liver, gallbladder diagnosis
By AuntMinnie.com staff writers
A software package designed to assist with the clinical diagnosis of liver and gallbladder diseases has been cleared by the U.S. Food and Drug Administration (FDA).
March 11, 2008
EUSA Pharma to acquire Cytogen
By AuntMinnie.com staff writers
Specialty pharmaceutical company EUSA Pharma of Oxford, U.K., has entered into a definitive agreement to acquire biopharmaceutical firm Cytogen for $22.6 million.
March 10, 2008
PET/CT beats 3T MRI in whole-body primary tumor staging
By Rob Skelding
VIENNA - Finding how far a patient's cancer has spread is critical in planning and optimizing treatment. Various imaging techniques now provide indispensable tools for staging primary tumors, but a new comparative study found fused whole-body PET/CT to be significantly more accurate than whole-body MRI -- even at 3 tesla -- for primary tumor staging.
March 9, 2008
UC-Davis develops PET/MRI scanner
By AuntMinnie.com staff writers
The biomedical engineering department at the University of California, Davis, has developed a PET/MRI scanner. The system is designed to study laboratory mice for cancer research, according to Simon Cherry, professor and chair of biomedical engineering.
March 6, 2008
IBA posts mixed results for 2007
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve posted strong revenue increases but also a decline in profit in 2007.
March 6, 2008
Reactor shutdown hurts MDS Nordion's Q1
By AuntMinnie.com staff writers
The shutdown last year of the Chalk River nuclear reactor in Canada affected the first-quarter financial results of radioisotope developer MDS Nordion.
March 5, 2008
Previous Page
Page 439 of 612
Next Page